Drug Safety Alert Generation and Overriding in a Large Dutch University Medical Centre
Overview
Public Health
Affiliations
Purpose: To evaluate numbers and types of drug safety alerts generated and overridden in a large Dutch university medical centre.
Methods: A disguised observation study lasting 25 days on two internal medicine wards evaluating alert generation and handling of alerts. A retrospective analysis was also performed of all drug safety alerts overridden in the hospital using pharmacy log files over 24 months.
Results: In the disguised observation study 34% of the orders generated a drug safety alert of which 91% were overridden. The majority of alerts generated (56%) concerned drug-drug interactions (DDIs) and these were overridden more often (98%) than overdoses (89%) or duplicate orders (80%). All drug safety alerts concerning admission medicines were overridden.Retrospective analysis of pharmacy log files for all wards revealed one override per five prescriptions. Of all overrides, DDIs accounted for 59%, overdoses 24% and duplicate orders 17%. DDI alerts of medium-level seriousness were overridden more often (55%) than low-level (22%) or high-level DDIs (19%). In 36% of DDI overrides, it would have been possible to monitor effects by measuring serum levels. The top 20 of overridden DDIs accounted for 76% of all DDI overrides.
Conclusions: Drug safety alerts were generated in one third of orders and were frequently overridden. Duplicate order alerts more often resulted in order cancellation (20%) than did alerts for overdose (11%) or DDIs (2%). DDIs were most frequently overridden. Only a small number of DDIs caused these overrides. Studies on improvement of alert handling should focus on these frequently-overridden DDIs.
Almanaa M Cureus. 2024; 16(9):e69470.
PMID: 39411619 PMC: 11479669. DOI: 10.7759/cureus.69470.
Bauer J, Busse M, Kopetzky T, Seggewies C, Fromm M, Dorje F Appl Clin Inform. 2024; 15(3):637-649.
PMID: 39084615 PMC: 11290949. DOI: 10.1055/s-0044-1787184.
Imai S, Momo K, Kashiwagi H, Sato Y, Miyai T, Sugawara M Ann Clin Epidemiol. 2024; 4(1):6-10.
PMID: 38505281 PMC: 10760476. DOI: 10.37737/ace.22002.
Fayea Alasiri S, Douiri A, Altukistani S, Porat T, Mousa O Perspect Health Inf Manag. 2023; 20(2):1d.
PMID: 37293480 PMC: 10245087.
Patel D, Msosa Y, Wang T, Mustafa O, Gee S, Williams J BMC Med Inform Decis Mak. 2022; 22(1):100.
PMID: 35421974 PMC: 9009062. DOI: 10.1186/s12911-022-01842-5.